Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon May 05, 2021 6:04pm
60 Views
Post# 33137384

SALP (Thomson family) ARE SELLING

SALP (Thomson family) ARE SELLINGAt the year end 2020 SALP owned 23 992 231 shares  (70,4 % ownership) page 125 annual report.

In the Notice for the AGM, page 12...SALP owned 19 876 129 shares representing 66 .4 ownership


GOOD NEWS ARE COMMING ? WHY DID THEY SELL 4% OF THEIR SHARES ?

THEY RECOVERED $ 20 MILLIONS WITH FAKE NEWS




 
<< Previous
Bullboard Posts
Next >>